• Our Company

QuintilesIMS Delivers Integrated Information and Technology Solutions to Drive Healthcare Forward

Around the world healthcare stakeholders are working to improve real-world patient outcomes through treatment innovations, care provision and access to healthcare. For the information, technology and service solutions they need to drive new insights and approaches, they count on QuintilesIMS. With a global team of 50,000, we harness insights, commercial and scientific depth, and executional expertise to empower clients to achieve some of their most important goals: Improving clinical, scientific and commercial results. Realizing the full potential of innovations. And, ultimately, driving healthcare forward.

For more information please visit www.quintilesims.com.

Driving Healthcare Performance in Slovenia

Established in Ljubljana in 1992, QuintilesIMS Slovenia offers solutions for the healthcare industry including promotional data, wholesaler based market information and wide range of consulting services.

In 2011, QuintilesIMS Slovenia signed a partnership agreement with Medisim resulting in improved coverage of the healthcare market. We have introduced a new, advanced analytical tool IMS Market Viewer with enhanced functionalities and reporting capabilities that help clients identify threats and capture opportunities. Furthermore, we have combined ethical and healthcare markets into one database enabling clients to monitor the whole registered and some parts of the unregistered market in Slovenia.

In 2012, the size of the pharmaceutical market in Slovenia (retail and hospital) reached €494 million in 2012 (Ex-MNF price), decreasing almost 4% compared to the previous year. The leading therapy area in this period was L Antineoplast+Immunomodul, with 5.9 % increase compared to the previous year. The top therapeutic class in 2011 was Cardiovascular, which in 2012 dropped by 8% from 2011 in terms of wholesaler value. 184 corporations currently operate in the Slovenian pharmaceutical market with ten accounting for 63% of total market sales in 2012.